SMTL ID : 6wgl.1

Dupilumab fab with Crystal Kappa design complexed with human IL-4 receptor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.82 Å

Oligo State

hetero-1-1-1-mer

Ligands

2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 3 residues within 4Å: Chain C: N.28, T.31, N.53 No protein-ligand interaction detected (PLIP) NAG-NAG.2: 6 residues within 4Å: Chain C: V.40, N.73, T.75, K.87, S.89, K.91 No protein-ligand interaction detected (PLIP)

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.3: 4 residues within 4Å: Chain C: E.94, H.95, Y.183, N.184 2 PLIP interactions: 2 interactions with chain C Hydrophobic interactions: C:Y.183 Hydrogen bonds: C:N.184

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lieu, R. et al., Rapid and robust antibody Fab fragment crystallization utilizing edge-to-edge beta-sheet packing. Plos One (2020)

Release Date

2020-09-16

Peptides

Dupilumab Fab heavy chain: A
Dupilumab Fab light chain: B
Interleukin-4 receptor subunit alpha: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

Dupilumab Fab heavy chain

Dupilumab Fab light chain

Interleukin-4 receptor subunit alpha

Related Entries With Identical Sequence